nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—HTR2A—trigeminal nucleus—multiple sclerosis	0.0957	0.266	CbGeAlD
Amisulpride—HTR7—pons—multiple sclerosis	0.0284	0.0789	CbGeAlD
Amisulpride—HTR2A—trigeminal nerve—multiple sclerosis	0.0251	0.0699	CbGeAlD
Amisulpride—HTR7—peripheral nervous system—multiple sclerosis	0.0189	0.0525	CbGeAlD
Amisulpride—HTR2A—pons—multiple sclerosis	0.0177	0.0492	CbGeAlD
Amisulpride—HTR7—nerve—multiple sclerosis	0.0147	0.0409	CbGeAlD
Amisulpride—DRD2—nerve—multiple sclerosis	0.0139	0.0387	CbGeAlD
Amisulpride—HTR2A—pineal body—multiple sclerosis	0.0126	0.0351	CbGeAlD
Amisulpride—HTR2A—peripheral nervous system—multiple sclerosis	0.0118	0.0327	CbGeAlD
Amisulpride—HTR2A—nerve—multiple sclerosis	0.00918	0.0255	CbGeAlD
Amisulpride—Sulpiride—BCHE—multiple sclerosis	0.00799	1	CrCbGaD
Amisulpride—DRD3—nervous system—multiple sclerosis	0.0074	0.0206	CbGeAlD
Amisulpride—DRD3—central nervous system—multiple sclerosis	0.00712	0.0198	CbGeAlD
Amisulpride—HTR7—brainstem—multiple sclerosis	0.00632	0.0176	CbGeAlD
Amisulpride—DRD2—brainstem—multiple sclerosis	0.00597	0.0166	CbGeAlD
Amisulpride—DRD2—retina—multiple sclerosis	0.00576	0.016	CbGeAlD
Amisulpride—DRD3—brain—multiple sclerosis	0.00566	0.0157	CbGeAlD
Amisulpride—HTR7—medulla oblongata—multiple sclerosis	0.00441	0.0123	CbGeAlD
Amisulpride—HTR7—midbrain—multiple sclerosis	0.00403	0.0112	CbGeAlD
Amisulpride—HTR2A—brainstem—multiple sclerosis	0.00394	0.011	CbGeAlD
Amisulpride—HTR7—spinal cord—multiple sclerosis	0.00393	0.0109	CbGeAlD
Amisulpride—HTR2B—nervous system—multiple sclerosis	0.00387	0.0107	CbGeAlD
Amisulpride—DRD2—midbrain—multiple sclerosis	0.00381	0.0106	CbGeAlD
Amisulpride—HTR2A—retina—multiple sclerosis	0.0038	0.0106	CbGeAlD
Amisulpride—HTR2B—central nervous system—multiple sclerosis	0.00372	0.0103	CbGeAlD
Amisulpride—HTR7—nervous system—multiple sclerosis	0.00331	0.00921	CbGeAlD
Amisulpride—HTR7—central nervous system—multiple sclerosis	0.00319	0.00886	CbGeAlD
Amisulpride—DRD2—nervous system—multiple sclerosis	0.00313	0.0087	CbGeAlD
Amisulpride—HTR7—cerebellum—multiple sclerosis	0.00312	0.00866	CbGeAlD
Amisulpride—DRD2—central nervous system—multiple sclerosis	0.00301	0.00838	CbGeAlD
Amisulpride—HTR2B—brain—multiple sclerosis	0.00295	0.00822	CbGeAlD
Amisulpride—DRD2—cerebellum—multiple sclerosis	0.00295	0.00819	CbGeAlD
Amisulpride—HTR2A—medulla oblongata—multiple sclerosis	0.00275	0.00764	CbGeAlD
Amisulpride—HTR7—brain—multiple sclerosis	0.00253	0.00704	CbGeAlD
Amisulpride—HTR2A—midbrain—multiple sclerosis	0.00251	0.00698	CbGeAlD
Amisulpride—HTR2A—spinal cord—multiple sclerosis	0.00245	0.00681	CbGeAlD
Amisulpride—DRD2—brain—multiple sclerosis	0.00239	0.00665	CbGeAlD
Amisulpride—HTR2A—nervous system—multiple sclerosis	0.00206	0.00574	CbGeAlD
Amisulpride—HTR2A—central nervous system—multiple sclerosis	0.00199	0.00553	CbGeAlD
Amisulpride—HTR2A—cerebellum—multiple sclerosis	0.00194	0.0054	CbGeAlD
Amisulpride—Cardiac arrest—Methylprednisolone—multiple sclerosis	0.00192	0.00403	CcSEcCtD
Amisulpride—Bradycardia—Mitoxantrone—multiple sclerosis	0.00189	0.00396	CcSEcCtD
Amisulpride—Hypotension—Cladribine—multiple sclerosis	0.00188	0.00393	CcSEcCtD
Amisulpride—Sweating increased—Prednisolone—multiple sclerosis	0.00186	0.00389	CcSEcCtD
Amisulpride—Vaginal inflammation—Methotrexate—multiple sclerosis	0.00185	0.00386	CcSEcCtD
Amisulpride—Pulmonary embolism—Methotrexate—multiple sclerosis	0.00185	0.00386	CcSEcCtD
Amisulpride—Insomnia—Cladribine—multiple sclerosis	0.00182	0.00381	CcSEcCtD
Amisulpride—Leukopenia—Azathioprine—multiple sclerosis	0.00179	0.00375	CcSEcCtD
Amisulpride—Somnolence—Cladribine—multiple sclerosis	0.00179	0.00374	CcSEcCtD
Amisulpride—Cardiac arrest—Betamethasone—multiple sclerosis	0.00175	0.00366	CcSEcCtD
Amisulpride—Cardiac arrest—Dexamethasone—multiple sclerosis	0.00175	0.00366	CcSEcCtD
Amisulpride—Vaginal infection—Methotrexate—multiple sclerosis	0.00174	0.00365	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00174	0.00363	CcSEcCtD
Amisulpride—Weight increased—Prednisolone—multiple sclerosis	0.00174	0.00363	CcSEcCtD
Amisulpride—Fatigue—Cladribine—multiple sclerosis	0.00173	0.00363	CcSEcCtD
Amisulpride—Constipation—Cladribine—multiple sclerosis	0.00172	0.0036	CcSEcCtD
Amisulpride—Sweating increased—Triamcinolone—multiple sclerosis	0.00171	0.00358	CcSEcCtD
Amisulpride—Sweating increased—Methylprednisolone—multiple sclerosis	0.0017	0.00357	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00169	0.00355	CcSEcCtD
Amisulpride—Neuropathy peripheral—Prednisolone—multiple sclerosis	0.00167	0.00349	CcSEcCtD
Amisulpride—Gynaecomastia—Methotrexate—multiple sclerosis	0.00165	0.00346	CcSEcCtD
Amisulpride—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00164	0.00344	CcSEcCtD
Amisulpride—Urticaria—Cladribine—multiple sclerosis	0.0016	0.00334	CcSEcCtD
Amisulpride—Weight increased—Triamcinolone—multiple sclerosis	0.0016	0.00334	CcSEcCtD
Amisulpride—Weight increased—Methylprednisolone—multiple sclerosis	0.00159	0.00333	CcSEcCtD
Amisulpride—Abdominal pain—Cladribine—multiple sclerosis	0.00159	0.00333	CcSEcCtD
Amisulpride—Skin disorder—Azathioprine—multiple sclerosis	0.00159	0.00332	CcSEcCtD
Amisulpride—HTR2A—brain—multiple sclerosis	0.00158	0.00439	CbGeAlD
Amisulpride—Bradycardia—Prednisolone—multiple sclerosis	0.00155	0.00325	CcSEcCtD
Amisulpride—Sweating increased—Dexamethasone—multiple sclerosis	0.00155	0.00324	CcSEcCtD
Amisulpride—Sweating increased—Betamethasone—multiple sclerosis	0.00155	0.00324	CcSEcCtD
Amisulpride—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.00153	0.00321	CcSEcCtD
Amisulpride—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.00153	0.0032	CcSEcCtD
Amisulpride—Hypotension—Azathioprine—multiple sclerosis	0.00153	0.0032	CcSEcCtD
Amisulpride—Cardiac arrest—Prednisone—multiple sclerosis	0.00152	0.00319	CcSEcCtD
Amisulpride—Hypersensitivity—Cladribine—multiple sclerosis	0.00148	0.0031	CcSEcCtD
Amisulpride—Leukopenia—Mitoxantrone—multiple sclerosis	0.00145	0.00303	CcSEcCtD
Amisulpride—Weight increased—Dexamethasone—multiple sclerosis	0.00145	0.00303	CcSEcCtD
Amisulpride—Weight increased—Betamethasone—multiple sclerosis	0.00145	0.00303	CcSEcCtD
Amisulpride—Asthenia—Cladribine—multiple sclerosis	0.00144	0.00302	CcSEcCtD
Amisulpride—Weight decreased—Betamethasone—multiple sclerosis	0.00144	0.00301	CcSEcCtD
Amisulpride—Weight decreased—Dexamethasone—multiple sclerosis	0.00144	0.00301	CcSEcCtD
Amisulpride—Hyperglycaemia—Betamethasone—multiple sclerosis	0.00144	0.003	CcSEcCtD
Amisulpride—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.00144	0.003	CcSEcCtD
Amisulpride—Bradycardia—Triamcinolone—multiple sclerosis	0.00143	0.00299	CcSEcCtD
Amisulpride—Bradycardia—Methylprednisolone—multiple sclerosis	0.00143	0.00298	CcSEcCtD
Amisulpride—Pruritus—Cladribine—multiple sclerosis	0.00142	0.00298	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00141	0.00295	CcSEcCtD
Amisulpride—Convulsion—Mitoxantrone—multiple sclerosis	0.0014	0.00294	CcSEcCtD
Amisulpride—Hypertension—Mitoxantrone—multiple sclerosis	0.0014	0.00293	CcSEcCtD
Amisulpride—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.00139	0.00291	CcSEcCtD
Amisulpride—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.00139	0.00291	CcSEcCtD
Amisulpride—Diarrhoea—Cladribine—multiple sclerosis	0.00138	0.00288	CcSEcCtD
Amisulpride—Anxiety—Mitoxantrone—multiple sclerosis	0.00137	0.00288	CcSEcCtD
Amisulpride—Sweating increased—Prednisone—multiple sclerosis	0.00135	0.00283	CcSEcCtD
Amisulpride—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00134	0.0028	CcSEcCtD
Amisulpride—Dizziness—Cladribine—multiple sclerosis	0.00133	0.00278	CcSEcCtD
Amisulpride—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.0013	0.00272	CcSEcCtD
Amisulpride—Bradycardia—Dexamethasone—multiple sclerosis	0.0013	0.00271	CcSEcCtD
Amisulpride—Bradycardia—Betamethasone—multiple sclerosis	0.0013	0.00271	CcSEcCtD
Amisulpride—Neutropenia—Prednisone—multiple sclerosis	0.0013	0.00271	CcSEcCtD
Amisulpride—Abdominal pain—Azathioprine—multiple sclerosis	0.00129	0.00271	CcSEcCtD
Amisulpride—Skin disorder—Mitoxantrone—multiple sclerosis	0.00128	0.00269	CcSEcCtD
Amisulpride—Vomiting—Cladribine—multiple sclerosis	0.00128	0.00268	CcSEcCtD
Amisulpride—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00128	0.00267	CcSEcCtD
Amisulpride—Erectile dysfunction—Prednisone—multiple sclerosis	0.00128	0.00267	CcSEcCtD
Amisulpride—Angiopathy—Methylprednisolone—multiple sclerosis	0.00127	0.00266	CcSEcCtD
Amisulpride—Immune system disorder—Methylprednisolone—multiple sclerosis	0.00126	0.00265	CcSEcCtD
Amisulpride—Weight increased—Prednisone—multiple sclerosis	0.00126	0.00264	CcSEcCtD
Amisulpride—Headache—Cladribine—multiple sclerosis	0.00126	0.00264	CcSEcCtD
Amisulpride—Weight decreased—Prednisone—multiple sclerosis	0.00125	0.00262	CcSEcCtD
Amisulpride—Hyperglycaemia—Prednisone—multiple sclerosis	0.00125	0.00262	CcSEcCtD
Amisulpride—Hypotension—Mitoxantrone—multiple sclerosis	0.00124	0.00259	CcSEcCtD
Amisulpride—Depression—Prednisone—multiple sclerosis	0.00123	0.00258	CcSEcCtD
Amisulpride—Mental disorder—Methylprednisolone—multiple sclerosis	0.00123	0.00257	CcSEcCtD
Amisulpride—Malnutrition—Methylprednisolone—multiple sclerosis	0.00122	0.00255	CcSEcCtD
Amisulpride—Angioedema—Prednisolone—multiple sclerosis	0.00121	0.00254	CcSEcCtD
Amisulpride—Neuropathy peripheral—Prednisone—multiple sclerosis	0.00121	0.00254	CcSEcCtD
Amisulpride—Hypersensitivity—Azathioprine—multiple sclerosis	0.0012	0.00252	CcSEcCtD
Amisulpride—Nausea—Cladribine—multiple sclerosis	0.00119	0.0025	CcSEcCtD
Amisulpride—Somnolence—Mitoxantrone—multiple sclerosis	0.00118	0.00246	CcSEcCtD
Amisulpride—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00116	0.00244	CcSEcCtD
Amisulpride—Angiopathy—Dexamethasone—multiple sclerosis	0.00116	0.00242	CcSEcCtD
Amisulpride—Angiopathy—Betamethasone—multiple sclerosis	0.00116	0.00242	CcSEcCtD
Amisulpride—Convulsion—Prednisolone—multiple sclerosis	0.00115	0.00241	CcSEcCtD
Amisulpride—Hypertension—Prednisolone—multiple sclerosis	0.00115	0.0024	CcSEcCtD
Amisulpride—Fatigue—Mitoxantrone—multiple sclerosis	0.00114	0.00239	CcSEcCtD
Amisulpride—Constipation—Mitoxantrone—multiple sclerosis	0.00113	0.00237	CcSEcCtD
Amisulpride—Bradycardia—Prednisone—multiple sclerosis	0.00113	0.00236	CcSEcCtD
Amisulpride—Diarrhoea—Azathioprine—multiple sclerosis	0.00112	0.00234	CcSEcCtD
Amisulpride—Angioedema—Triamcinolone—multiple sclerosis	0.00112	0.00234	CcSEcCtD
Amisulpride—Angioedema—Methylprednisolone—multiple sclerosis	0.00111	0.00233	CcSEcCtD
Amisulpride—Neutropenia—Methotrexate—multiple sclerosis	0.00108	0.00227	CcSEcCtD
Amisulpride—Dizziness—Azathioprine—multiple sclerosis	0.00108	0.00226	CcSEcCtD
Amisulpride—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00108	0.00226	CcSEcCtD
Amisulpride—Erectile dysfunction—Methotrexate—multiple sclerosis	0.00107	0.00223	CcSEcCtD
Amisulpride—Convulsion—Triamcinolone—multiple sclerosis	0.00106	0.00222	CcSEcCtD
Amisulpride—Convulsion—Methylprednisolone—multiple sclerosis	0.00106	0.00221	CcSEcCtD
Amisulpride—Hypertension—Triamcinolone—multiple sclerosis	0.00105	0.00221	CcSEcCtD
Amisulpride—Hypertension—Methylprednisolone—multiple sclerosis	0.00105	0.0022	CcSEcCtD
Amisulpride—Urticaria—Mitoxantrone—multiple sclerosis	0.00105	0.0022	CcSEcCtD
Amisulpride—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00105	0.00219	CcSEcCtD
Amisulpride—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00104	0.00219	CcSEcCtD
Amisulpride—Vomiting—Azathioprine—multiple sclerosis	0.00104	0.00218	CcSEcCtD
Amisulpride—Anxiety—Methylprednisolone—multiple sclerosis	0.00103	0.00217	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00103	0.00216	CcSEcCtD
Amisulpride—Depression—Methotrexate—multiple sclerosis	0.00103	0.00216	CcSEcCtD
Amisulpride—Headache—Azathioprine—multiple sclerosis	0.00102	0.00214	CcSEcCtD
Amisulpride—Dry mouth—Triamcinolone—multiple sclerosis	0.00102	0.00213	CcSEcCtD
Amisulpride—Angioedema—Betamethasone—multiple sclerosis	0.00101	0.00212	CcSEcCtD
Amisulpride—Angioedema—Dexamethasone—multiple sclerosis	0.00101	0.00212	CcSEcCtD
Amisulpride—Angiopathy—Prednisone—multiple sclerosis	0.00101	0.00211	CcSEcCtD
Amisulpride—Immune system disorder—Prednisone—multiple sclerosis	0.001	0.0021	CcSEcCtD
Amisulpride—Insomnia—Prednisolone—multiple sclerosis	0.000981	0.00205	CcSEcCtD
Amisulpride—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000976	0.00204	CcSEcCtD
Amisulpride—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000974	0.00204	CcSEcCtD
Amisulpride—Mental disorder—Prednisone—multiple sclerosis	0.000972	0.00203	CcSEcCtD
Amisulpride—Nausea—Azathioprine—multiple sclerosis	0.000971	0.00203	CcSEcCtD
Amisulpride—Skin disorder—Methylprednisolone—multiple sclerosis	0.000966	0.00202	CcSEcCtD
Amisulpride—Malnutrition—Prednisone—multiple sclerosis	0.000965	0.00202	CcSEcCtD
Amisulpride—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000964	0.00202	CcSEcCtD
Amisulpride—Agranulocytosis—Methotrexate—multiple sclerosis	0.000964	0.00202	CcSEcCtD
Amisulpride—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000962	0.00201	CcSEcCtD
Amisulpride—Convulsion—Dexamethasone—multiple sclerosis	0.000961	0.00201	CcSEcCtD
Amisulpride—Convulsion—Betamethasone—multiple sclerosis	0.000961	0.00201	CcSEcCtD
Amisulpride—Hypertension—Dexamethasone—multiple sclerosis	0.000957	0.002	CcSEcCtD
Amisulpride—Hypertension—Betamethasone—multiple sclerosis	0.000957	0.002	CcSEcCtD
Amisulpride—Asthenia—Mitoxantrone—multiple sclerosis	0.000948	0.00199	CcSEcCtD
Amisulpride—Anxiety—Dexamethasone—multiple sclerosis	0.000941	0.00197	CcSEcCtD
Amisulpride—Anxiety—Betamethasone—multiple sclerosis	0.000941	0.00197	CcSEcCtD
Amisulpride—Hypotension—Methylprednisolone—multiple sclerosis	0.00093	0.00195	CcSEcCtD
Amisulpride—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000904	0.00189	CcSEcCtD
Amisulpride—Insomnia—Triamcinolone—multiple sclerosis	0.000902	0.00189	CcSEcCtD
Amisulpride—Insomnia—Methylprednisolone—multiple sclerosis	0.0009	0.00188	CcSEcCtD
Amisulpride—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000887	0.00186	CcSEcCtD
Amisulpride—Nervous system disorder—Betamethasone—multiple sclerosis	0.000887	0.00186	CcSEcCtD
Amisulpride—Agitation—Prednisone—multiple sclerosis	0.000887	0.00186	CcSEcCtD
Amisulpride—Angioedema—Prednisone—multiple sclerosis	0.000882	0.00185	CcSEcCtD
Amisulpride—Dyspepsia—Triamcinolone—multiple sclerosis	0.000878	0.00184	CcSEcCtD
Amisulpride—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000876	0.00183	CcSEcCtD
Amisulpride—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000875	0.00183	CcSEcCtD
Amisulpride—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000875	0.00183	CcSEcCtD
Amisulpride—Urticaria—Prednisolone—multiple sclerosis	0.000861	0.0018	CcSEcCtD
Amisulpride—Cardiac disorder—Methotrexate—multiple sclerosis	0.00086	0.0018	CcSEcCtD
Amisulpride—Fatigue—Triamcinolone—multiple sclerosis	0.00086	0.0018	CcSEcCtD
Amisulpride—Fatigue—Methylprednisolone—multiple sclerosis	0.000858	0.0018	CcSEcCtD
Amisulpride—Hypotension—Betamethasone—multiple sclerosis	0.000845	0.00177	CcSEcCtD
Amisulpride—Hypotension—Dexamethasone—multiple sclerosis	0.000845	0.00177	CcSEcCtD
Amisulpride—Angiopathy—Methotrexate—multiple sclerosis	0.000841	0.00176	CcSEcCtD
Amisulpride—Vomiting—Mitoxantrone—multiple sclerosis	0.00084	0.00176	CcSEcCtD
Amisulpride—Immune system disorder—Methotrexate—multiple sclerosis	0.000837	0.00175	CcSEcCtD
Amisulpride—Convulsion—Prednisone—multiple sclerosis	0.000837	0.00175	CcSEcCtD
Amisulpride—Hypertension—Prednisone—multiple sclerosis	0.000834	0.00175	CcSEcCtD
Amisulpride—Headache—Mitoxantrone—multiple sclerosis	0.000828	0.00173	CcSEcCtD
Amisulpride—Anxiety—Prednisone—multiple sclerosis	0.000819	0.00171	CcSEcCtD
Amisulpride—Insomnia—Dexamethasone—multiple sclerosis	0.000818	0.00171	CcSEcCtD
Amisulpride—Insomnia—Betamethasone—multiple sclerosis	0.000818	0.00171	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000816	0.00171	CcSEcCtD
Amisulpride—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000814	0.0017	CcSEcCtD
Amisulpride—Mental disorder—Methotrexate—multiple sclerosis	0.000812	0.0017	CcSEcCtD
Amisulpride—Malnutrition—Methotrexate—multiple sclerosis	0.000807	0.00169	CcSEcCtD
Amisulpride—Hypersensitivity—Prednisolone—multiple sclerosis	0.000799	0.00167	CcSEcCtD
Amisulpride—Dyspepsia—Dexamethasone—multiple sclerosis	0.000796	0.00167	CcSEcCtD
Amisulpride—Dyspepsia—Betamethasone—multiple sclerosis	0.000796	0.00167	CcSEcCtD
Amisulpride—Urticaria—Triamcinolone—multiple sclerosis	0.000792	0.00166	CcSEcCtD
Amisulpride—Urticaria—Methylprednisolone—multiple sclerosis	0.00079	0.00165	CcSEcCtD
Amisulpride—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000787	0.00165	CcSEcCtD
Amisulpride—Nausea—Mitoxantrone—multiple sclerosis	0.000785	0.00164	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000781	0.00164	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000781	0.00164	CcSEcCtD
Amisulpride—Fatigue—Betamethasone—multiple sclerosis	0.00078	0.00163	CcSEcCtD
Amisulpride—Fatigue—Dexamethasone—multiple sclerosis	0.00078	0.00163	CcSEcCtD
Amisulpride—Nervous system disorder—Prednisone—multiple sclerosis	0.000773	0.00162	CcSEcCtD
Amisulpride—Skin disorder—Prednisone—multiple sclerosis	0.000765	0.0016	CcSEcCtD
Amisulpride—Hyperhidrosis—Prednisone—multiple sclerosis	0.000762	0.00159	CcSEcCtD
Amisulpride—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00074	0.00155	CcSEcCtD
Amisulpride—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00074	0.00155	CcSEcCtD
Amisulpride—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000735	0.00154	CcSEcCtD
Amisulpride—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000733	0.00153	CcSEcCtD
Amisulpride—Leukopenia—Methotrexate—multiple sclerosis	0.000722	0.00151	CcSEcCtD
Amisulpride—Urticaria—Dexamethasone—multiple sclerosis	0.000719	0.0015	CcSEcCtD
Amisulpride—Urticaria—Betamethasone—multiple sclerosis	0.000719	0.0015	CcSEcCtD
Amisulpride—Dizziness—Prednisolone—multiple sclerosis	0.000717	0.0015	CcSEcCtD
Amisulpride—Asthenia—Triamcinolone—multiple sclerosis	0.000715	0.0015	CcSEcCtD
Amisulpride—Abdominal pain—Betamethasone—multiple sclerosis	0.000715	0.0015	CcSEcCtD
Amisulpride—Abdominal pain—Dexamethasone—multiple sclerosis	0.000715	0.0015	CcSEcCtD
Amisulpride—Asthenia—Methylprednisolone—multiple sclerosis	0.000714	0.00149	CcSEcCtD
Amisulpride—Insomnia—Prednisone—multiple sclerosis	0.000713	0.00149	CcSEcCtD
Amisulpride—Pruritus—Triamcinolone—multiple sclerosis	0.000706	0.00148	CcSEcCtD
Amisulpride—Pruritus—Methylprednisolone—multiple sclerosis	0.000704	0.00147	CcSEcCtD
Amisulpride—Convulsion—Methotrexate—multiple sclerosis	0.000699	0.00146	CcSEcCtD
Amisulpride—Dyspepsia—Prednisone—multiple sclerosis	0.000694	0.00145	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000682	0.00143	CcSEcCtD
Amisulpride—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000681	0.00143	CcSEcCtD
Amisulpride—Fatigue—Prednisone—multiple sclerosis	0.000679	0.00142	CcSEcCtD
Amisulpride—Headache—Prednisolone—multiple sclerosis	0.000679	0.00142	CcSEcCtD
Amisulpride—Constipation—Prednisone—multiple sclerosis	0.000674	0.00141	CcSEcCtD
Amisulpride—Dizziness—Triamcinolone—multiple sclerosis	0.000659	0.00138	CcSEcCtD
Amisulpride—Dizziness—Methylprednisolone—multiple sclerosis	0.000658	0.00138	CcSEcCtD
Amisulpride—Asthenia—Betamethasone—multiple sclerosis	0.000649	0.00136	CcSEcCtD
Amisulpride—Asthenia—Dexamethasone—multiple sclerosis	0.000649	0.00136	CcSEcCtD
Amisulpride—Nervous system disorder—Methotrexate—multiple sclerosis	0.000646	0.00135	CcSEcCtD
Amisulpride—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000644	0.00135	CcSEcCtD
Amisulpride—Nausea—Prednisolone—multiple sclerosis	0.000644	0.00135	CcSEcCtD
Amisulpride—Pruritus—Dexamethasone—multiple sclerosis	0.00064	0.00134	CcSEcCtD
Amisulpride—Pruritus—Betamethasone—multiple sclerosis	0.00064	0.00134	CcSEcCtD
Amisulpride—Skin disorder—Methotrexate—multiple sclerosis	0.00064	0.00134	CcSEcCtD
Amisulpride—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000637	0.00133	CcSEcCtD
Amisulpride—Vomiting—Triamcinolone—multiple sclerosis	0.000634	0.00133	CcSEcCtD
Amisulpride—Vomiting—Methylprednisolone—multiple sclerosis	0.000633	0.00132	CcSEcCtD
Amisulpride—Urticaria—Prednisone—multiple sclerosis	0.000626	0.00131	CcSEcCtD
Amisulpride—Headache—Triamcinolone—multiple sclerosis	0.000625	0.00131	CcSEcCtD
Amisulpride—Headache—Methylprednisolone—multiple sclerosis	0.000623	0.0013	CcSEcCtD
Amisulpride—Abdominal pain—Prednisone—multiple sclerosis	0.000623	0.0013	CcSEcCtD
Amisulpride—Diarrhoea—Dexamethasone—multiple sclerosis	0.000619	0.0013	CcSEcCtD
Amisulpride—Diarrhoea—Betamethasone—multiple sclerosis	0.000619	0.0013	CcSEcCtD
Amisulpride—Hypotension—Methotrexate—multiple sclerosis	0.000615	0.00129	CcSEcCtD
Amisulpride—Dizziness—Dexamethasone—multiple sclerosis	0.000598	0.00125	CcSEcCtD
Amisulpride—Dizziness—Betamethasone—multiple sclerosis	0.000598	0.00125	CcSEcCtD
Amisulpride—Insomnia—Methotrexate—multiple sclerosis	0.000596	0.00125	CcSEcCtD
Amisulpride—Nausea—Triamcinolone—multiple sclerosis	0.000592	0.00124	CcSEcCtD
Amisulpride—Nausea—Methylprednisolone—multiple sclerosis	0.000591	0.00124	CcSEcCtD
Amisulpride—Somnolence—Methotrexate—multiple sclerosis	0.000585	0.00123	CcSEcCtD
Amisulpride—Hypersensitivity—Prednisone—multiple sclerosis	0.000581	0.00122	CcSEcCtD
Amisulpride—Dyspepsia—Methotrexate—multiple sclerosis	0.00058	0.00121	CcSEcCtD
Amisulpride—Vomiting—Betamethasone—multiple sclerosis	0.000575	0.0012	CcSEcCtD
Amisulpride—Vomiting—Dexamethasone—multiple sclerosis	0.000575	0.0012	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000569	0.00119	CcSEcCtD
Amisulpride—Fatigue—Methotrexate—multiple sclerosis	0.000568	0.00119	CcSEcCtD
Amisulpride—Headache—Betamethasone—multiple sclerosis	0.000567	0.00119	CcSEcCtD
Amisulpride—Headache—Dexamethasone—multiple sclerosis	0.000567	0.00119	CcSEcCtD
Amisulpride—Asthenia—Prednisone—multiple sclerosis	0.000565	0.00118	CcSEcCtD
Amisulpride—Pruritus—Prednisone—multiple sclerosis	0.000557	0.00117	CcSEcCtD
Amisulpride—Diarrhoea—Prednisone—multiple sclerosis	0.000539	0.00113	CcSEcCtD
Amisulpride—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000538	0.00113	CcSEcCtD
Amisulpride—Nausea—Betamethasone—multiple sclerosis	0.000537	0.00113	CcSEcCtD
Amisulpride—Nausea—Dexamethasone—multiple sclerosis	0.000537	0.00113	CcSEcCtD
Amisulpride—Urticaria—Methotrexate—multiple sclerosis	0.000523	0.0011	CcSEcCtD
Amisulpride—Dizziness—Prednisone—multiple sclerosis	0.000521	0.00109	CcSEcCtD
Amisulpride—Abdominal pain—Methotrexate—multiple sclerosis	0.000521	0.00109	CcSEcCtD
Amisulpride—Vomiting—Prednisone—multiple sclerosis	0.000501	0.00105	CcSEcCtD
Amisulpride—Headache—Prednisone—multiple sclerosis	0.000494	0.00103	CcSEcCtD
Amisulpride—Hypersensitivity—Methotrexate—multiple sclerosis	0.000485	0.00102	CcSEcCtD
Amisulpride—Asthenia—Methotrexate—multiple sclerosis	0.000472	0.000989	CcSEcCtD
Amisulpride—Nausea—Prednisone—multiple sclerosis	0.000468	0.00098	CcSEcCtD
Amisulpride—Pruritus—Methotrexate—multiple sclerosis	0.000466	0.000975	CcSEcCtD
Amisulpride—Diarrhoea—Methotrexate—multiple sclerosis	0.000451	0.000943	CcSEcCtD
Amisulpride—Dizziness—Methotrexate—multiple sclerosis	0.000435	0.000912	CcSEcCtD
Amisulpride—Vomiting—Methotrexate—multiple sclerosis	0.000419	0.000877	CcSEcCtD
Amisulpride—Headache—Methotrexate—multiple sclerosis	0.000413	0.000864	CcSEcCtD
Amisulpride—Nausea—Methotrexate—multiple sclerosis	0.000391	0.000819	CcSEcCtD
Amisulpride—DRD3—GPCR ligand binding—CCL2—multiple sclerosis	0.000149	0.000962	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—S1PR1—multiple sclerosis	0.000147	0.000953	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000147	0.000951	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—CCR5—multiple sclerosis	0.000146	0.000947	CbGpPWpGaD
Amisulpride—HTR7—Circadian rythm related genes—IL6—multiple sclerosis	0.000145	0.00094	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—S1PR1—multiple sclerosis	0.000145	0.000938	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—CCL5—multiple sclerosis	0.000143	0.000928	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—GPC5—multiple sclerosis	0.000143	0.000927	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CNR1—multiple sclerosis	0.000143	0.000924	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCR1—multiple sclerosis	0.000142	0.000918	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CXCL13—multiple sclerosis	0.000142	0.000918	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000142	0.000916	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000141	0.000913	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—GPC5—multiple sclerosis	0.000141	0.000912	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000139	0.000898	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CXCL10—multiple sclerosis	0.000138	0.000894	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000137	0.000884	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000134	0.000867	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000132	0.000853	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—CCL5—multiple sclerosis	0.000131	0.000848	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CCL3—multiple sclerosis	0.000131	0.000847	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CCR2—multiple sclerosis	0.000131	0.000844	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—CCL5—multiple sclerosis	0.00013	0.000842	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—CCR5—multiple sclerosis	0.000129	0.000836	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CCL3—multiple sclerosis	0.000129	0.000834	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CXCL10—multiple sclerosis	0.000129	0.000832	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CCR2—multiple sclerosis	0.000128	0.00083	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000127	0.000824	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PTGER4—multiple sclerosis	0.000126	0.000816	CbGpPWpGaD
Amisulpride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000126	0.000814	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—RGS1—multiple sclerosis	0.000125	0.00081	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PTGER4—multiple sclerosis	0.000124	0.000802	CbGpPWpGaD
Amisulpride—DRD3—Circadian rythm related genes—IL6—multiple sclerosis	0.000124	0.000799	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—RGS1—multiple sclerosis	0.000123	0.000797	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—CCL5—multiple sclerosis	0.000122	0.000789	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CXCR3—multiple sclerosis	0.000122	0.000788	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CNR1—multiple sclerosis	0.00012	0.000779	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CXCR3—multiple sclerosis	0.00012	0.000775	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CCL5—multiple sclerosis	0.000119	0.00077	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCL3—multiple sclerosis	0.000119	0.000769	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—GPR65—multiple sclerosis	0.000119	0.000768	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CCR2—multiple sclerosis	0.000119	0.000766	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CNR1—multiple sclerosis	0.000119	0.000766	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—CCR5—multiple sclerosis	0.000118	0.000764	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—CCR5—multiple sclerosis	0.000117	0.000759	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—GPR65—multiple sclerosis	0.000117	0.000756	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CCR2—multiple sclerosis	0.000117	0.000754	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000116	0.000753	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—POMC—multiple sclerosis	0.000116	0.000752	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—IL2RA—multiple sclerosis	0.000116	0.000748	CbGpPWpGaD
Amisulpride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000115	0.000742	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PTGER4—multiple sclerosis	0.000115	0.00074	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—POMC—multiple sclerosis	0.000114	0.00074	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000114	0.000737	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—CCL2—multiple sclerosis	0.000114	0.000736	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PGR—multiple sclerosis	0.000113	0.000729	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—CCL2—multiple sclerosis	0.000112	0.000724	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CCL5—multiple sclerosis	0.000111	0.000716	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CXCR3—multiple sclerosis	0.000111	0.000715	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—CCR5—multiple sclerosis	0.00011	0.000711	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CD28—multiple sclerosis	0.00011	0.000708	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CNR1—multiple sclerosis	0.000109	0.000707	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCL3—multiple sclerosis	0.000109	0.000703	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CXCL13—multiple sclerosis	0.000109	0.000702	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCR1—multiple sclerosis	0.000109	0.000702	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000108	0.000701	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000108	0.0007	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CNR1—multiple sclerosis	0.000108	0.000696	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCR2—multiple sclerosis	0.000108	0.000696	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CCR5—multiple sclerosis	0.000107	0.000693	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCR1—multiple sclerosis	0.000107	0.000691	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CXCL13—multiple sclerosis	0.000107	0.000691	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000107	0.00069	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—IL2RA—multiple sclerosis	0.000106	0.000683	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PTGER4—multiple sclerosis	0.000105	0.000677	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PGR—multiple sclerosis	0.000103	0.000666	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCL3—multiple sclerosis	0.000101	0.000654	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CXCR3—multiple sclerosis	0.000101	0.000654	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—POMC—multiple sclerosis	0.000101	0.000653	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CD28—multiple sclerosis	0.0001	0.000647	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CCR5—multiple sclerosis	9.98e-05	0.000645	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CNR1—multiple sclerosis	9.93e-05	0.000642	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CXCL10—multiple sclerosis	9.85e-05	0.000637	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—IL2RA—multiple sclerosis	9.84e-05	0.000636	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCR2—multiple sclerosis	9.83e-05	0.000636	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PTGER4—multiple sclerosis	9.74e-05	0.00063	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CXCL10—multiple sclerosis	9.69e-05	0.000626	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PGR—multiple sclerosis	9.59e-05	0.00062	CbGpPWpGaD
Amisulpride—DRD2—Circadian rythm related genes—IL6—multiple sclerosis	9.46e-05	0.000612	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CXCR3—multiple sclerosis	9.41e-05	0.000608	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CCL5—multiple sclerosis	9.34e-05	0.000604	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CD28—multiple sclerosis	9.32e-05	0.000602	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—POMC—multiple sclerosis	9.23e-05	0.000597	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CCL5—multiple sclerosis	9.19e-05	0.000594	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—POMC—multiple sclerosis	9.17e-05	0.000593	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCR2—multiple sclerosis	9.15e-05	0.000592	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CNR1—multiple sclerosis	9.08e-05	0.000587	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—CCL2—multiple sclerosis	8.98e-05	0.00058	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CXCL10—multiple sclerosis	8.94e-05	0.000578	CbGpPWpGaD
Amisulpride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	8.82e-05	0.00057	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—POMC—multiple sclerosis	8.59e-05	0.000555	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CCL5—multiple sclerosis	8.48e-05	0.000548	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CNR1—multiple sclerosis	8.44e-05	0.000546	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—CCR5—multiple sclerosis	8.41e-05	0.000544	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—POMC—multiple sclerosis	8.38e-05	0.000542	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CCL5—multiple sclerosis	8.34e-05	0.000539	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—IL2RA—multiple sclerosis	8.29e-05	0.000536	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—CCR5—multiple sclerosis	8.28e-05	0.000535	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—CCL2—multiple sclerosis	8.2e-05	0.00053	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CXCL10—multiple sclerosis	8.17e-05	0.000528	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—IL2RA—multiple sclerosis	8.16e-05	0.000527	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—TYK2—multiple sclerosis	8.15e-05	0.000527	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CD86—multiple sclerosis	7.82e-05	0.000505	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—POMC—multiple sclerosis	7.8e-05	0.000504	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCL3—multiple sclerosis	7.74e-05	0.000501	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCL5—multiple sclerosis	7.7e-05	0.000498	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CCR5—multiple sclerosis	7.64e-05	0.000494	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—CCL2—multiple sclerosis	7.63e-05	0.000493	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCL3—multiple sclerosis	7.62e-05	0.000492	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CXCL10—multiple sclerosis	7.6e-05	0.000492	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL2RA—multiple sclerosis	7.53e-05	0.000487	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CCR5—multiple sclerosis	7.52e-05	0.000486	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—IL2—multiple sclerosis	7.47e-05	0.000483	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PTGER4—multiple sclerosis	7.45e-05	0.000482	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—TYK2—multiple sclerosis	7.45e-05	0.000482	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL2RA—multiple sclerosis	7.41e-05	0.000479	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PGR—multiple sclerosis	7.34e-05	0.000474	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PTGER4—multiple sclerosis	7.33e-05	0.000474	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PGR—multiple sclerosis	7.22e-05	0.000467	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CXCR3—multiple sclerosis	7.2e-05	0.000465	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CD86—multiple sclerosis	7.15e-05	0.000462	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CD28—multiple sclerosis	7.13e-05	0.000461	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—SPP1—multiple sclerosis	7.13e-05	0.000461	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CXCR3—multiple sclerosis	7.08e-05	0.000458	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCL5—multiple sclerosis	7.03e-05	0.000455	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CD28—multiple sclerosis	7.02e-05	0.000454	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCR2—multiple sclerosis	7e-05	0.000453	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCR5—multiple sclerosis	6.93e-05	0.000448	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—TYK2—multiple sclerosis	6.93e-05	0.000448	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCR2—multiple sclerosis	6.89e-05	0.000445	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL2RA—multiple sclerosis	6.83e-05	0.000442	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—IL2—multiple sclerosis	6.83e-05	0.000441	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—IL2—multiple sclerosis	6.78e-05	0.000438	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CD86—multiple sclerosis	6.65e-05	0.00043	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—POMC—multiple sclerosis	6.57e-05	0.000425	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCL5—multiple sclerosis	6.54e-05	0.000423	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SPP1—multiple sclerosis	6.51e-05	0.000421	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—POMC—multiple sclerosis	6.47e-05	0.000418	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CNR1—multiple sclerosis	6.46e-05	0.000418	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CNR1—multiple sclerosis	6.36e-05	0.000411	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—IL2—multiple sclerosis	6.35e-05	0.000411	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCR5—multiple sclerosis	6.34e-05	0.00041	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—APOE—multiple sclerosis	6.31e-05	0.000408	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL2RA—multiple sclerosis	6.25e-05	0.000404	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—IL2—multiple sclerosis	6.2e-05	0.000401	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SPP1—multiple sclerosis	6.06e-05	0.000392	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—POMC—multiple sclerosis	5.97e-05	0.000386	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCR5—multiple sclerosis	5.9e-05	0.000381	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—POMC—multiple sclerosis	5.87e-05	0.00038	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CCL2—multiple sclerosis	5.84e-05	0.000378	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CXCL10—multiple sclerosis	5.82e-05	0.000376	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL2RA—multiple sclerosis	5.81e-05	0.000376	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—IL2—multiple sclerosis	5.77e-05	0.000373	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—APOE—multiple sclerosis	5.77e-05	0.000373	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CCL2—multiple sclerosis	5.75e-05	0.000372	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CXCL10—multiple sclerosis	5.72e-05	0.00037	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CD80—multiple sclerosis	5.7e-05	0.000369	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—POMC—multiple sclerosis	5.42e-05	0.00035	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—APOE—multiple sclerosis	5.36e-05	0.000347	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—TYK2—multiple sclerosis	5.3e-05	0.000343	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCL2—multiple sclerosis	5.3e-05	0.000343	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—TYK2—multiple sclerosis	5.22e-05	0.000337	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CD80—multiple sclerosis	5.21e-05	0.000337	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—MAPK1—multiple sclerosis	5.19e-05	0.000335	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CD86—multiple sclerosis	5.09e-05	0.000329	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCL5—multiple sclerosis	5.01e-05	0.000324	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CD86—multiple sclerosis	5.01e-05	0.000324	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—POMC—multiple sclerosis	4.95e-05	0.00032	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	4.93e-05	0.000319	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	4.86e-05	0.000314	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CD80—multiple sclerosis	4.85e-05	0.000314	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCL2—multiple sclerosis	4.85e-05	0.000313	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TYK2—multiple sclerosis	4.82e-05	0.000311	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	4.78e-05	0.000309	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—MAPK1—multiple sclerosis	4.74e-05	0.000307	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SPP1—multiple sclerosis	4.64e-05	0.0003	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—POMC—multiple sclerosis	4.61e-05	0.000298	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	4.56e-05	0.000295	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCR5—multiple sclerosis	4.51e-05	0.000292	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCL2—multiple sclerosis	4.51e-05	0.000291	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	4.45e-05	0.000287	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	4.44e-05	0.000287	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL2—multiple sclerosis	4.41e-05	0.000285	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—MAPK1—multiple sclerosis	4.41e-05	0.000285	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TYK2—multiple sclerosis	4.4e-05	0.000284	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	4.38e-05	0.000283	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	4.34e-05	0.000281	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APOE—multiple sclerosis	4.1e-05	0.000265	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TYK2—multiple sclerosis	4.09e-05	0.000265	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APOE—multiple sclerosis	4.04e-05	0.000261	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL2—multiple sclerosis	4.01e-05	0.000259	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—IL6—multiple sclerosis	3.99e-05	0.000258	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MMP9—multiple sclerosis	3.79e-05	0.000245	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CD80—multiple sclerosis	3.71e-05	0.00024	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL2—multiple sclerosis	3.66e-05	0.000237	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CD80—multiple sclerosis	3.65e-05	0.000236	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	3.64e-05	0.000236	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—POMC—multiple sclerosis	3.53e-05	0.000228	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—POMC—multiple sclerosis	3.47e-05	0.000224	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	3.47e-05	0.000224	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCL2—multiple sclerosis	3.45e-05	0.000223	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL2—multiple sclerosis	3.41e-05	0.00022	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	3.39e-05	0.000219	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—IL6—multiple sclerosis	3.39e-05	0.000219	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	3.38e-05	0.000218	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—STAT3—multiple sclerosis	3.37e-05	0.000218	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	3.32e-05	0.000215	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MMP9—multiple sclerosis	3.22e-05	0.000208	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TYK2—multiple sclerosis	3.13e-05	0.000203	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MYC—multiple sclerosis	3.13e-05	0.000203	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TGFB1—multiple sclerosis	3.13e-05	0.000202	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	3.08e-05	0.000199	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	3.08e-05	0.000199	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MAPK1—multiple sclerosis	3.06e-05	0.000198	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—STAT3—multiple sclerosis	2.87e-05	0.000185	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MYC—multiple sclerosis	2.86e-05	0.000185	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	2.86e-05	0.000185	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	2.8e-05	0.000181	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MYC—multiple sclerosis	2.66e-05	0.000172	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TGFB1—multiple sclerosis	2.66e-05	0.000172	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL2—multiple sclerosis	2.61e-05	0.000169	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MAPK1—multiple sclerosis	2.61e-05	0.000168	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL6—multiple sclerosis	2.59e-05	0.000168	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL2—multiple sclerosis	2.57e-05	0.000166	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	2.55e-05	0.000165	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MMP9—multiple sclerosis	2.47e-05	0.00016	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	2.43e-05	0.000157	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL6—multiple sclerosis	2.36e-05	0.000152	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—STAT3—multiple sclerosis	2.19e-05	0.000142	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	2.16e-05	0.00014	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL6—multiple sclerosis	2.15e-05	0.000139	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MYC—multiple sclerosis	2.04e-05	0.000132	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	2.03e-05	0.000131	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MYC—multiple sclerosis	2.01e-05	0.00013	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL6—multiple sclerosis	2e-05	0.000129	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	2e-05	0.000129	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	1.99e-05	0.000129	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	1.96e-05	0.000127	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL6—multiple sclerosis	1.53e-05	9.91e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL6—multiple sclerosis	1.51e-05	9.75e-05	CbGpPWpGaD
